CNTG - CENTOGENE to Present at H.C. Wainwright 25th Annual Global Investment Conference | Benzinga
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Centogene N.V. (NASDAQ:CNTG), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today announced that CENTOGENE CEO Kim Stratton will present in the virtual track at the H.C. Wainwright 25th Annual Global Investment Conference being held September 11-13, 2023, and invites investors to participate via virtual one-on-one meetings with Ms. Stratton and CENTOGENE CFO Miguel Coego Rios.
Please see details below:
H.C. Wainwright 25th Annual Global Investment Conference
| Dates: |
| Sept. 11-13 |
| Location: |
| Virtual |
| Format: |
| Company Presentation and One-on-One Meetings |
| Presentation Webcast*: |
| https://link.centogene.com/centogene-hc-wainwright |
*A replay will be available for 90 days following the presentation.
Please contact your representative at H.C. Wainwright to schedule a virtual one-on-one meeting with CENTOGENE during the conference. For information about the H.C. Wainwright Global Investment Conference, please refer to the events website (https://hcwevents.com/annualconference/).
About CENTOGENE
CENTOGENE's mission is to provide data-driven, life-changing answers to patients, physicians, and pharma companies for rare and neurodegenerative diseases. We integrate multiomic technologies with the CENTOGENE Biodatabank – providing dimensional analysis to guide the next generation of precision medicine. Our unique approach enables rapid and reliable diagnosis ...